Determinants of transition states in MDMA self-administration

MDMA 自我给药过渡态的决定因素

基本信息

  • 批准号:
    8387029
  • 负责人:
  • 金额:
    $ 37.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-02-01 至 2015-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidemiological reports show that (1)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") continues to be used by large fractions of young adults. Studies have further suggested that up to 40 percent of users become at least temporarily dependent on MDMA, experienced users abuse an array of other substances and may abuse MDMA several times per week or even daily. It is also known that some Ecstasy users exhibit lasting cognitive and mood alterations, even years after discontinuing Ecstasy use. Nevertheless, in comparison with structurally related drugs such as amphetamine and methamphetamine minimal animal research has been devoted to understanding the determinants of repeated MDMA self-administration. Initial work has shown that MDMA appears to be a weak reinforcer compared with other psychomotor stimulants, thus additional study of factors which create a transition to frequent or compulsive MDMA use is needed. The hypothesis that differences in the self administration of MDMA are related to the increased serotonergic agonist properties of MDMA is supported by prior observations that drugs which increase serotonergic tone may decrease self- administration of psychomotor stimulants. Such work will not only contribute to understanding the development of MDMA/Ecstasy abuse but may generalize to understanding factors which influence which of a minority of individuals exposed to other psychomotor stimulants will eventually transition to dependence. The proposed studies will use rat intravenous self-administration models to test factors which may underlie a transition from casual to compulsive Ecstasy use. The experiments will first examine methodological variables such as training dose, route of administration and duration of access session that have not been systematically addressed for MDMA self-administration. Additional studies will examine situational factors intended to model the human user milieu (such as high ambient temperature and hyperthermia, running wheel activity and exposure to a serotonin-depleting high dose regimen of MDMA) which may facilitate a transition to dependence.
描述(由申请人提供):流行病学报告显示,大部分年轻人继续使用 (1)3,4-亚甲二氧基甲基苯丙胺(MDMA,“摇头丸”)。研究进一步表明,高达 40% 的使用者至少会暂时依赖 MDMA,有经验的使用者会滥用一系列其他物质,并且可能每周甚至每天滥用 MDMA 几次。众所周知,一些摇头丸使用者表现出持久的认知和情绪改变,甚至在停止使用摇头丸多年后也是如此。然而,与结构相关的药物(如苯丙胺和甲基苯丙胺)相比,极少的动物研究致力于了解重复 MDMA 自我给药的决定因素。初步研究表明,与其他精神运动兴奋剂相比,摇头丸似乎是一种较弱的强化剂,因此需要对导致频繁或强迫性使用摇头丸的因素进行进一步研究。 MDMA 自我给药的差异与 MDMA 血清素能激动剂特性增加有关的假设得到了先前观察的支持,即增加血清素能张力的药物可能会减少精神运动兴奋剂的自我给药。此类工作不仅有助于了解 MDMA/摇头丸滥用的发展,而且可能推广到了解影响少数接触其他精神运动兴奋剂的人最终会转变为依赖的因素。拟议的研究将使用大鼠静脉自我给药模型来测试可能导致从随意使用摇头丸到强迫使用摇头丸的转变的因素。实验将首先检查方法学变量,例如训练剂量、给药途径和访问会话持续时间,这些变量尚未针对 MDMA 自我管理进行系统解决。其他研究将检查旨在模拟人类使用者环境的情境因素(例如高环境温度和高热、跑轮活动和暴露于消耗血清素的高剂量 MDMA),这些因素可能会促进向依赖的转变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL A. TAFFE其他文献

MICHAEL A. TAFFE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL A. TAFFE', 18)}}的其他基金

Dissecting the Abuse Liability of Synthetic Cathinone Stimulants
剖析合成卡西酮兴奋剂的滥用责任
  • 批准号:
    9932085
  • 财政年份:
    2019
  • 资助金额:
    $ 37.68万
  • 项目类别:
Dissecting the Abuse Liability of Cathinone and Amphetamine Stimulants
剖析卡西酮和安非他明兴奋剂的滥用责任
  • 批准号:
    10668867
  • 财政年份:
    2016
  • 资助金额:
    $ 37.68万
  • 项目类别:
Prescription Opioid Addiction: Neurobiological Mechanisms
处方阿片类药物成瘾:神经生物学机制
  • 批准号:
    9024499
  • 财政年份:
    2014
  • 资助金额:
    $ 37.68万
  • 项目类别:
Cannabinoid regulation of cognition
大麻素对认知的调节
  • 批准号:
    8484251
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
Cannabinoid regulation of cognition
大麻素对认知的调节
  • 批准号:
    8739099
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
Cannabinoid regulation of cognition
大麻素对认知的调节
  • 批准号:
    8657029
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
Cannabinoid regulation of cognition
大麻素对认知的调节
  • 批准号:
    8793181
  • 财政年份:
    2013
  • 资助金额:
    $ 37.68万
  • 项目类别:
Determinants of transition states in MDMA self-administration
MDMA 自我给药过渡态的决定因素
  • 批准号:
    8580927
  • 财政年份:
    2011
  • 资助金额:
    $ 37.68万
  • 项目类别:
Determinants of transition states in MDMA self-administration
MDMA 自我给药过渡态的决定因素
  • 批准号:
    8063456
  • 财政年份:
    2011
  • 资助金额:
    $ 37.68万
  • 项目类别:
Determinants of transition states in MDMA self-administration
MDMA 自我给药过渡态的决定因素
  • 批准号:
    8773581
  • 财政年份:
    2011
  • 资助金额:
    $ 37.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了